Proteins that form the reovirus outer capsid play an active role in the entry of reovirus into host cells. Among these, the 1 protein mediates attachment of reovirus particles to host cells via interaction with cell surface glycans or the proteinaceous receptor junctional adhesion molecule A (JAM-A). The 1 protein functions to penetrate the host cell membrane to allow delivery of the genome-containing viral core particle into the cytoplasm to initiate viral replication. We demonstrate that a reassortant virus that expresses the M2 gene-encoded 1 protein derived from prototype strain T3D in an otherwise prototype T1L background (T1L/T3DM2) infects cells more efficiently than parental T1L. Unexpectedly, the enhancement in infectivity of T1L/T3DM2 is due to its capacity to attach to cells more efficiently. We present genetic data implicating the central region of 1 in altering the cell attachment property of reovirus. Our data indicate that the T3D 1-mediated enhancement in infectivity of T1L is dependent on the function of 1 and requires the expression of JAM-A. We also demonstrate that T1L/T3DM2 utilizes JAM-A more efficiently than T1L. These studies revealed a previously unknown relationship between two nonadjacent reovirus outer capsid proteins, 1 and 1.
A ttachment of virus is the first step in the infection of host cells.
Cell attachment occurs via interactions of viral attachment factors with host cell receptors. For enveloped viruses, viral glycoproteins embedded in the lipid membrane serve as attachment factors (1) . For nonenveloped viruses, specific structural features on the capsid or sequences within the exposed portion of the viral structural proteins bind host receptors (1) . Mutations within the receptor-binding site can alter the efficiency with which virus attaches to host cells and consequently modulate the capacity of the virus to establish infection. In viral systems where capsids are formed from multiple structural proteins, these proteins fit together in a precise geometric arrangement. Thus, changes to the properties of one capsid protein can influence the function of other capsid proteins. In this report, we highlight one such example by demonstrating a previously unknown functional relationship between two nonadjacent viral capsid proteins of mammalian orthoreovirus (reovirus).
Reovirus forms virions comprised of two concentric capsid shells (2) . The inner capsid or core encapsidates the 10 segments of genomic double-stranded RNA (dsRNA) and contains enzymes needed to launch virus replication upon entry into cells (2) . The viral outer capsid contains 3 capsid proteins, 1, 3, and 1, that play important roles in cell entry (3) . The 3 and 1 proteins form heterohexamers, 200 of which decorate the outer capsid (4, 5) . Among them, the 3 protein masks the cell penetration function of the 1 protein until the virion is proteolytically disassembled (3) . Attachment of the virion to the host cell occurs via trimers of the 1 protein (6, 7) , which are held onto virus particles at the icosahedral vertices of the particle via interaction with the turretforming 2 protein (4, 5, 8) .
The 1 protein interacts with host cells by associating with at least two types of receptors. 1 proteins from all serotypes of reovirus engage proteinaceous receptor junctional adhesion molecule A (JAM-A) (9, 10) . In addition, 1 engages a serotype-specific glycan receptor. Whereas serotype 1 (T1) 1 engages GM2, T3 1 engages glycans that terminate in sialic acid (11) (12) (13) (14) . Two other cell surface-localized host molecules, ␤1 integrin(s) and Ngr1, have also been implicated in facilitating reovirus entry and infection (15, 16) . Whether ␤1 integrin interacts with viral components is not known. Though Ngr1 has been demonstrated to interact directly with virus particles (16) , viral structures or proteins that participate in the interaction with Ngr1 remain to be identified.
We have previously characterized reovirus M2 gene reassortants in vitro to evaluate the conformational flexibility and membrane penetration properties of the M2-encoded 1 protein (17, 18) . Here we sought to examine the infectious properties of these viruses. We found that a reassortant type 1 reovirus with a type 3 M2 gene (T1L/T3DM2) establishes infection with greater efficiency than the parental T1L strain. Surprisingly, the enhanced infectivity of T1L/T3DM2 was related to an increase in its efficiency of binding to host cells in comparison to that of T1L. Our data suggest that the central region of the T3D-derived 1 protein affects the attachment efficiency of the virus. The increased infectivity of T1L/T3DM2 requires the function of the 1 attachment protein and expression of its cellular binding partner, JAM-A. Our studies revealed for the first time that the properties of the reovirus 1 protein affect viral infectivity by impacting the receptor-binding function of the nonadjacent 1 attachment protein.
MATERIALS AND METHODS
Cells. Spinner-adapted murine L929 cells were maintained in Joklik's minimum essential medium (MEM) (Lonza) supplemented to contain 5% fetal bovine serum (FBS) (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin (Invitrogen), 100 g/ml streptomycin (Invitrogen), and 25 ng/ml amphotericin B (Sigma-Aldrich). Spinner-adapted L929 cells were used for cultivating, purifying, and measuring the titers of viruses. L929 cells obtained from ATCC were maintained in Eagle's MEM (Lonza) supplemented to contain 5% fetal bovine serum (FBS) (Sigma-Aldrich) and 2 mM L-glutamine (Invitrogen). Experiments to measure attachment, infectivity, and cell death were done using L929 cells from ATCC. CHO cells transfected with empty vector (pCDNA3.1) or with pCDNA3.1 encoding human JAM-A were maintained in Ham's F12 medium supplemented to contain 5% fetal bovine serum (FBS) (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen), and 1 mg/ml G418 (Sigma-Aldrich). HeLa cells were maintained in Dulbecco's MEM supplemented to contain 5% fetal bovine serum (FBS) (Sigma-Aldrich) and 2 mM L-glutamine (Invitrogen). In experiments to determine the effect of GM2 binding, cells were pretreated at 37°C for 1 h with 100 mU/ml neuraminidase (MP Biomedicals or Roche) in serum-free media.
Generation of recombinant viruses. Recombinant strains T1L/ T3DM2, T1L/(DLD)M2, T1L/ (LDL)M2, T1L/T3DM2 A305V, T1L/  T3DM2 R327K, T1L/T3DM2 S340T, T1L/T3DM2 N342G, T1L/T3DM2  D517E, T1L/T3DS1, and T1L/T3DS1M2 , which contain a wild-type T3D gene, a chimeric or mutated M2 gene, or a T3D S1 gene in an otherwise T1L background, were generated by using a plasmid-based reverse-genetics strategy (19) . To confirm sequences of mutant viruses, viral RNA was extracted from infected cells and subjected to reverse transcription-PCR using three sets of M2-specific or S1-specific primer. PCR products were resolved on Tris-acetate-EDTA agarose gels, purified, and confirmed by sequence analysis.
Purification of viruses. Purified reovirus virions were generated using second-or third-passage L-cell lysate stocks of reovirus. Viral particles were extracted from infected cell lysates by the use of Vertrel-XF (Dupont), layered onto 1.2-to 1.4-g/cm 3 CsCl gradients, and centrifuged at 187,183 ϫ g for 4 h. Bands corresponding to virions (1.36 g/cm 3 ) were collected and dialyzed in virion storage buffer (150 mM NaCl, 15 mM MgCl 2 , 10 mM Tris-HCl [pH 7.4]) (20) . The concentration of reovirus virions in purified preparations was determined from an equivalence of 1 optical density (OD) unit at 260 nm equaling 2.1 ϫ 10 12 virions/ml (21) . Virus titers were determined using a standard plaque assay method and spinner-adapted L929 cells. Four different preparations of T1L and T1L/ T3DM2 were used for the experiments described in this paper. These are designated A, B, C, and D. The matched sets (particle-to-PFU ratios) were as follows: T1L-A (47) and T1L/T3DM2-A (42.5); T1L-B (262) and T1L/ T3DM2-B (630); T1L-C (656) and T1L/T3DM2-C (367); and T1L-D (438) and T1L/T3DM2-D (750). Three preparations of T1L/T3DS1 and T1L/T3DS1M2 were used. The matched sets (particle-to-PFU ratios) were as follows: T1L/T3DS1-A (3,330) and T1L/T3DS1M2-A (4,090); T1L/T3DS1-B (715) and T1L/T3DS1M2 (757); and T1L/T3DS1-C (542) and T1L/T3DS1M2-C (453). A single preparation of DLDM2 and a single preparation of LDLM2 were used, and their particle-to-PFU ratios were 1,640 and 889, respectively. The single amino substitutions (particle-to-PFU ratios) were as follows: A305V (20) , R327K (34), S340T (42.7), N342G (44.6) , and D517E (46.1).
Dynamic light scattering (DLS). The indicated virus stocks (2 ϫ 10 12 particles/ml) were analyzed using a Zetasizer Nano S dynamic light scattering system (Malvern Instruments). All measurements were made in a quartz Suprasil cuvette with a 3.00-mm-path length (Hellma Analytics). For each sample, the hydrodynamic diameter (D H ) was determined by averaging readings across 15 iterations.
Generation of ISVPs in vitro. Intermediate subviral particles (ISVPs) were generated in vitro by incubation of 2 ϫ 10 12 virions with 200 g/ml of TLCK (N␣-p-tosyl-L-lysine chloromethyl ketone)-treated chymotrypsin (CHT) in a total volume of 0.1 ml at 32°C in virion storage buffer (150 mM NaCl, 15 mM MgCl 2 , 10 mM Tris-HCl [pH 7.4]) for 60 min. Proteolysis was terminated by addition of 2 mM phenylmethylsulfonyl fluoride (PMSF) and incubation of reaction mixtures on ice. Generation of ISVPs was confirmed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie brilliant blue staining.
Assessment of infectivity by indirect immunofluorescence. Monolayers of L929 cells, CHO cells, or HeLa cells (4 ϫ 10 4 ) in 96-well plates were washed with phosphate-buffered saline (PBS) and infected with virions or ISVPs of the indicated reovirus strain at 4°C for 1 h. In experiments to examine the role of glycans in infection, the cells were pretreated with serum-free Eagle's MEM containing 100 mU/ml neuraminidase (Roche) at 37°C for 1 h prior to virus attachment. In experiments to examine the effect of 5C6 monoclonal Ab (MAb) or JAM-A glutathione S-transferase (GST-JAM-A) on virus infectivity, 1 ϫ 10 11 virus particles/ml were incubated at 4°C with various amounts of 5C6 MAb or GST-JAM-A overnight (22, 23) . The mixture was used to initiate infection as described above. Following removal of the inoculum, cells were washed with PBS and incubated in media appropriate to the cell type at 37°C for 18 h. Monolayers were fixed with 100 l of methanol at Ϫ20°C for a minimum of 30 min, washed twice with PBS, blocked with 2.5% immunoglobulin-free bovine serum albumin (BSA; Invitrogen)-PBS, and incubated with polyclonal rabbit anti-reovirus serum at a 1:5,000 dilution in PBS-0.25% Triton X-100 at room temperature for 30 min (24) . Monolayers were washed twice with PBS and incubated with a 1:5,000 dilution of Alexa Fluor 488-labeled anti-rabbit immunoglobulin G. Cells were stained with 0.5 g/ml 4=,6-diamidino-2-phenylindole (DAPI; Invitrogen) at a concentration of 1:10,000. Monolayers were washed with PBS, and infected cells were visualized by indirect immunofluorescence using a fluorescein isothiocyanate (FITC)/DAPI filter set on an Olympus 1X71 microscope. Infected cells were identified by the presence of intense cytoplasmic fluorescence that was excluded from the cells. No background staining of uninfected control monolayers was noted. Reovirus antigenpositive cells were quantified by counting fluorescent cells in random fields in triplicate wells at ϫ20 magnification. Percentages of reoviruspositive cells were calculated by counting infected cells per total (DAPIpositive) cells.
Quantitation of cell death by acridine orange and ethidium bromide (AOEB) staining. L929 cells grown in 96-well plates were adsorbed with virus at room temperature for 1 h. The percentage of dead cells was determined after incubation at 37°C for 48 or 72 h postinfection using AOEB staining. For each sample, a total of 600 cells were counted, and the percentage of isolated cells exhibiting orange staining (EB positivity) was determined by fluorescence microscopy using an FITC/tetramethyl rhodamine isocyanate (TRITC) filter set on Olympus IX71 microscope. As a control, cell death in mock-infected cells was also determined. Since cell death under these conditions was minimal (Ͻ3%), these data are not included.
Assessment of reovirus attachment to cells by flow cytometry. Confluent 150-mm-diameter dishes of L929 cells (2 ϫ 10 7 ) were washed with chilled PBS. The cells were detached using PBS supplemented with 20 mM EDTA (PBS-EDTA) and centrifuged at 1,000 ϫ g at 4°C for 5 min. The cells were resuspended to obtain 2 ϫ 10 6 cells per ml. Cell were adsorbed with virus particles at 4°C for 1 h with continuous rotation on a tube rotator. After removal of the inoculum, the cells were harvested and resuspended in PBS supplemented with 5% BSA (PBS-BSA). Reovirus-specific rabbit polyclonal antiserum at 1:2,500 was added, and the reaction mixture was incubated at 4°C for 30 min with continuous rotation. The cells were washed twice with PBS-BSA followed by incubation at 4°C for 30 min with Alexa Fluor 488-labeled goat anti-rabbit antibody at 1:1,000 in PBS-BSA with continuous rotation. The cells were washed twice with PBS-BSA prior to fixing with cold 1% paraformaldehyde-PBS. Viral attachment to cells was quantified using a BD FACSCalibur cell analyzer and the CellQuestPro software.
Assessment of reovirus attachment to cells by on-cell Western blotting. L929 cells grown in 96-well plates were chilled at 4°C for 15 min and then adsorbed with virions at 4°C for 1 h. Cells were washed with chilled PBS and blocked with PBS-BSA at 4°C for 10 min. Cells were then incubated with polyclonal rabbit anti-reovirus serum at a 1:2,500 dilution in PBS-BSA at 4°C for 30 min. The cells were washed twice with PBS-BSA followed by incubation with a 1:1,000 dilution of Alexa Fluor 750-labeled goat anti-rabbit antibody at 4°C for 30 min. After two washes with PBS-BSA, cells were stained with a 1:1,000 dilution of a DNA stain, DRAQ5 (Cell Signaling Technology), at 4°C for 5 min. Cells were washed and then fixed with 4% formaldehyde at room temperature for 20 min. The plate was scanned using an Odyssey infrared imager (Li-COR). Binding index was quantified by quantifying the ratio of green (reovirus) and red fluorescence (DRAQ5) using Image Studio Lite software (Li-COR).
Comparing reactivity of anti-reovirus polyclonal sera. High-affinitybinding polystyrene plates (Pierce) were coated at 4°C overnight with the indicated amount of T1L or T1L/T3DM2 resuspended in 0.1 M carbonate-bicarbonate buffer at pH 9.5. Plates were blocked at 4°C for 1 h with 2.5% BSA in virion storage buffer, followed by two washes with wash buffer (0.1% BSA, 0.05% Tween, virion storage buffer). The plates were stained at room temperature for 1 h with reovirus-specific rabbit polyclonal antiserum (1:5,000) followed by Alexa Fluor 750-labeled anti-rabbit antibody (1:1,000). The plate was scanned using an Odyssey infrared imager (Li-COR).
Assessment of virus attachment by plaque assay. L929 cells grown in 24-well plates were chilled at 4°C for 15 min and then adsorbed with 5 ϫ 10 4 virions/cell at 4°C for 1 h. Cells were washed with chilled PBS, overlaid with 0.5 ml PBS, and frozen at Ϫ80°C. Following two cycles of freezethaw, the cell-associated virus was quantified by plaque assay.
1/1 ratio by Western blot analysis. Purified T1L or T1L/T3DM2 virions (2 ϫ 10 10 particles) from 4 independent viral preparations were resolved on 10% SDS-PAGE gels and transferred to nitrocellulose membranes. The membranes were blocked with 5% milk-Tris-buffered saline (TBS) at room temperature for 1 h followed by incubation with 4A3 mouse anti-1 MAb (1:500) and rabbit anti-T1L 1 head antibody (1: 750) at room temperature for 1 h in blocking buffer (22, 25) . The membranes were washed with TBS supplemented with 0.1% Tween 20 (TBS-T) twice for 15 min and then incubated with Alexa Fluor-conjugated anti-mouse IgG (for 4A3) or with Alexa Fluor-conjugated antirabbit IgG (for 1 head) in blocking buffer. Following three washes, membranes were scanned using an Odyssey infrared imager (LI-COR). 1/1 ratios were calculated from the intensities of the 1 and 1 bands using Image Studio Lite software (Li-COR).
Hemagglutination (HA) assay. Purified T1L or T1L/T3DM2 virions (1 ϫ 10 11 particles) were serially diluted in 50 l of PBS in 96-well roundbottom microtiter plates (Corning-Costar). Human erythrocytes (Innovative Research Company) were washed twice with chilled PBS and were resuspended at a concentration of 1% (vol/vol) in PBS. Washed erythrocytes (50 l) were added to wells containing virus and incubated at 4°C overnight. HA titers were determined by calculating HA units. One HA unit is equal to the number of particles of virus in the well with the lowest dilution of virus that shows a "shield."
Expression and purification of GST-JAM-A.
The plasmid for expressing the extracellular region of human JAM-A fused to the C terminus of glutathione S-transferase (GST) (GST-JAM-A) (23) was obtained from Terence Dermody (University of Pittsburgh School of Medicine). The vector encodes a thrombin cleavage site between GST and JAM-A. The GST-JAM-A expression plasmid was transformed into Rosetta-gami 2 chemically competent cells (Novagen). For large-scale protein expression and purification, cells were grown in Terrific Broth medium supplemented with 100 g/ml ampicillin and 37 g/ml chloramphenicol at 37°C. When the optical density at 600 nm reached 0.4 to 0.6, JAM-A GST expression was induced with 1 mM isopropyl-␤-D-thiogalactopyranoside and the cells were grown at 16°C for an additional 18 h. Following protein expression, the cells were pelleted at 5,000 ϫ g at 4°C for 15 min. The cell pellets were resuspended in a reaction mixture containing 50 mM Tris (pH 8), 150 mM NaCl, 100 g/ml lysozyme, 1 mM phenylmethylsulfonyl fluoride, and 0.1% Triton X-100. The cells were then lysed by sonication. Unlysed cells and cell debris were removed by ultracentrifugation at 125,000 ϫ g at 4°C for 30 min, and the clarified lysates were filtered through a 0.2-m-pore-size syringe filter. GST-JAM-A was purified by affinity chromatography using Pierce glutathione agarose (Thermo Fisher Scientific) following the manufacturer's instructions. GST-JAM-A was eluted from the glutathione agarose with 50 mM Tris (pH 8), 150 mM NaCl, and 25 mM reduced glutathione. Fractions containing JAM-A GST were exchanged into 50 mM Tris (pH 8) and 150 mM NaCl by dialysis. The concentration of purified GST-JAM-A was determined by DC protein assay (Bio-Rad). JAM-A GST purity was assessed by SDS-PAGE and Coomassie brilliant blue staining. For experiments utilizing JAM-A, JAM-A GST that had been affinity purified using glutathione agarose was treated with 15 units of thrombin (GE Healthcare) at 16°C overnight with continuous rotation. The released material was separated from the beads, and thrombin was inactivated using 0.3 mM PMSF.
In vitro binding assay. High-affinity-binding polystyrene plates (Pierce) were coated at 4°C overnight with 20 g/ml of purified JAM-A protein diluted in 0.1 M carbonate-bicarbonate buffer at pH 9.5. Plates were blocked at 4°C for 1 h with 2.5% BSA in virion storage buffer, followed by two washes with wash buffer (0.1% BSA, 0.05% Tween, virion storage buffer). T1L or T1L/T3DM2 virions were allowed to bind at 4°C for 2 h. After two washes with wash buffer, the plates were stained at room temperature for 1 h with reovirus-specific rabbit polyclonal antiserum (1:5,000) followed by Alexa Fluor 750-labeled anti-rabbit antibody (1: 1,000). The plate was scanned using Odyssey infrared imager (LI-COR).
Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 deletion of JAM-A. HeLa S3 cells were transfected with pSpCas9(BB)-2A-Puro (Addgene 48131) or pSpCas9(BB)-2A-Puro-JAM-A using Fugene 6 (Promega). To generate pSpCas9(BB)-2A-Puro-JAM-A, the guide sequence targeting human JAM-A was inserted into pSpCas9(BB)-2A-Puro by annealing forward (5=-CACCGGGACAAAGG CGCAAGTCGAG-3=) and reverse (5=-AAACCTCGACTTGCGCCTTTG TCC-3=) primers and insertion into the Bbs1 site. At 48 h posttransfection, cells were incubated for 2 passages with media containing 1 g/ml puromycin (Sigma-Aldrich) and media without puromycin thereafter. Cell surface JAM-A expression was confirmed by flow cytometry using JAM-A-specific antibody (J10.4).
Statistical analysis. The statistical significance of results of comparisons between experimental groups was determined by one-way analysis of variance (ANOVA) with Bonferroni's multiple-comparison test using Graphpad Prism software. When only two groups of samples were analyzed, the unpaired t test function was used.
PFU ratios are included in Materials and Methods). During characterization of its properties in L929 cells, we observed that T1L/ T3DM2 produces significantly more infected cells at 18 h postinfection than T1L (Fig. 1A) . This phenomenon was also ob-served in HeLa cells ( Fig. 1B) , indicating that the differences in infectivity are not restricted to a single cell type. Infection of a variety of host cells with reovirus results in cell death (26) (27) (28) (29) . In parallel with the greater capacity of T1L/T3DM2 to establish infection, we found that T1L/T3DM2 induced a higher level of cell death in L929 cells than T1L/T3DM2 (Fig. 1C ). To rule out the possibility that the aggregation of viruses contributed to the observed increase in the infectivity and cytotoxicity of T1L/T3DM2, we compared virions of T1L and T1L/T3DM2 using dynamic light scattering. We detected only one peak with the expected hydrodynamic diameter for both virus preparations, with no evidence of aggregation in either sample (Fig. 1D ). Thus, our data indicate that the presence of the T3DM2 gene segment in an otherwise T1L-specific genetic background enhances the capacity of T1L to establish infection and kill host cells.
T1L/T3DM2 attaches to host cells more efficiently. Based on the superior capacity of T3D 1-containing viruses to complete events required for cell penetration (17, 30, 31) , we expected that the enhanced infectivity of T1L/T3DM2 would be due to its capacity to more efficiently cross cell membranes and initiate infection. However, to rule out the possibility that events prior to membrane penetration were impacted by the presence of T3DM2, we first assessed the capacity of T1L and T1L/T3DM2 to attach to host cells using flow cytometry. We observed that the mean fluorescence intensity of binding of T1L/T3DM2 was, surprisingly, greater than that of T1L ( Fig. 2A and B ). Using a fluorescencebased quantitative binding assay on adherent cells, we also observed that at lower multiplicities of infection (MOIs), T1L/ T3DM2 bound to cells more efficiently than T1L in L929 cells ( Fig.  2C and D) . These data indicate that the presence of T3D 1 in a T1L virus enhances attachment to cells. When the MOI was increased to 1 ϫ 10 6 particles per cell or more, the two viruses bound to cells equivalently. These data indicate that the difference in binding efficiency can be overcome at higher concentrations. In the experiments described above, bound virus was detected by anti-reovirus polyclonal serum. To ensure that the differences in binding efficiency were not a function of the capacity of the polyclonal anti-reovirus serum to detect T1L and T1L/T3DM2, we tested the reactivity of these antisera to plate-coated T1L and T1L/ T3DM2. We found that the antisera bound T1L ϳ1.2 times better than T1L/T3DM2 ( Fig. 2E ). Thus, the increased attachment efficiency of T1L/T3DM2 was not an artifact of the method of detection. As an independent measure of virus attachment efficiency, we measured the amount of infectious virus attached to cells using plaque assay. Consistent with our measurement with other assays, we found that the cell-associated titer of T1L/T3DM2 was significantly higher than that of T1L. Together, these results indicate that T1L/T3DM2 attaches to cells more efficiently than T1L.
The central portion of the 1 protein impacts virus attachment. With the goal of identifying determinants within T3D 1 that affect the binding and infectivity of T1L viruses, we used viruses expressing chimeric T1L-T3D 1 proteins ( Fig. 3A) (17) . The 1 protein generates three cleavage fragments, 1N, ␦, and , during the course of infection (3) . The 1N portions of T1L and T3D 1 are identical (17) . We observed that a strain encoding DLD 1 (T1L/DLDM2), where the N-terminal portion of ␦ (␦ N ) is from T3D, the C-terminal portion of ␦ (␦ C ) is from T1L, and is from T3D (17), bound to cells as efficiently as T1L. In contrast, a strain encoding LDL 1 (T1L/LDLM2) displayed the binding efficiency characteristic of T1L/T3DM2 (Fig. 3B) . These data in- dicate that ␦ C is responsible for the difference in the levels of attachment efficiency of the virus strains. The ␦ C portion of 1 forms a jelly-roll beta barrel domain (32) . The sequences of ␦ C in T1L and T3D differ by five amino acids (17, 18) . To test the contribution of each of the T1L-T3D polymorphic residues, we compared the cell attachment capacities of T1L viruses expressing T3D 1 substituted with one of the five corresponding T1L residues. We found that each of the five substitution mutants displayed enhanced attachment similar to that seen with T1L/T3DM2 (Fig.  3C ). Though we were unable to identify a single residue in ␦ C that is responsible for the increase in attachment of T1L/T3DM2, these studies indicate that the presence of the T3D-derived ␦ C domain enhanced the capacity of T1L to attach cells. The 1-mediated increase in attachment efficiency is a function of T1L 1. Thus far, we have demonstrated that the presence of T3D 1 in a T1L virus (T1L/T3DM2) enhances the attachment of virions to the host cell. The 1 protein mediates attachment of reovirus to host cells (6, 7) . Though the T1L and T3D 1 polypeptide chains have low sequence homology, they fold into nearly identical trimeric fibers (10, 33) . The 1 proteins of both the T1L and T3D prototype reovirus strains engage JAM-A via their head domains (13, 33, 34) . However, the T1L and T3D 1 proteins engage distinct glycan receptors via disparate portions of the 1 trimer (13, 14) . We therefore asked if the presence of T3D 1 influences the attachment of viruses containing T3D 1 to host cells. For these experiments, we utilized recombinantly generated T1L/T3DS1 and T1L/T3DS1M2 and tested their capacity to infect cells. We observed that T1L/T3DS1 and T1L/T3DS1M2 were equally infectious (Fig. 4A) . Moreover, these two viruses attached to cells with equivalent levels of efficiency (Fig. 4B) . These studies suggested that the 1-dependent enhancement in attachment efficiency is manifested only in viruses expressing T1L 1.
To directly determine if attachment of T1L/T3DM2 was dependent on T1L 1, we assessed the capacity of a T1L 1 head-specific monoclonal antibody, 5C6, to block infection of T1L and T1L/T3DM2 (22) . For these experiments, virions incubated with 5C6 were allowed to attach to and infect L929 cells. We observed a decrease in the infectivity and attachment of both viruses (Fig. 5) . These data suggest that attachment and infection by both T1L and T1L/T3DM2 are 1 dependent and that the difference in the levels of infectivity of these two viruses cannot be attributed to the use of an alternative, as-yet-unidentified viral attachment factor.
The enhanced capacity of T1L/T3DM2 to infect and bind cells is lost upon ISVP formation. Though a complete virus particle is expected to have 12 1 trimers, virus strains with fewer 1 molecules remain infectious and may even display greater infectivity under some conditions (35, 36) . Thus, one possible reason for the difference in the affinities of T1L and T1L/T3DM2 for host cells could be that these virus strains encapsidate different amounts of 1 proteins. To test this idea, we measured the 1/1 ratio in three independent freshly purified virus preparations using a quantitative immunoblot method. We found that the 1/1 ratios of T1L and T1L/T3DM2 are equivalent ( Fig. 6A and B) . These data suggest that T1L and T1L/T3DM2 contain equivalent levels of 1. Analysis of the glycan binding property of reovirus can be used as an alternative method to quantify 1 levels (37) . For these experiments, the capacity of T1L and T1L/T3DM2 to agglutinate human erythrocytes was measured. Our data indicate that the hemagglutination titers of T1L and T1L/T3DM2 are equivalent ( Fig. 6C ). Together, our data indicate that the difference in the levels of attachment efficiency of T1L and T1L/T3DM2 is not related to differences in the levels of the viral attachment protein.
The 1 proteins of T1L and T1L/T3DM2 are identical. Moreover, these virus strains contain the same amount of the 1 protein ( Fig. 6A to C) . One possible reason for the differences in the capacities of these two viruses to interact with cells could be that their 1 proteins are in different conformations. When virions are converted to ISVPs, 1 assumes a more extended conformation (5, 8) . We therefore tested whether the differences in infectivity and cell attachment efficiency were affected by ISVP formation. In contrast with what we observed with virions, the infectivities of T1L and T1L/T3DM2 ISVPs were equivalent (Fig. 6D) . Correspondingly, the cell binding efficiencies of ISVPs of the two virus strains were also similar (Fig. 6E) . These data suggest that the difference in the conformational states of 1 on virions of T1L and Enhanced infection by T1L/T3DM2 requires JAM-A. The sensitivity of T1L/T3DM2 to 5C6 suggests that T1L/T3DM2 binds to cells via 1. 5C6 blocks attachment of 1 to both the T1 glycan receptor GM2 and the proteinaceous receptor JAM-A (9, 14) . One possible explanation for the increased attachment of T1L/T3DM2 could be that T1L/T3DM2 binds to one or both of these receptors more efficiently than T1L. To determine if this is the case, we first assessed whether T1L and T1L/T3DM2 are differentially sensitive to enzymatic removal of GM2. For these experiments, cells were treated with Arthrobacter ureafaciens neuraminidase. While this treatment significantly reduced infection by T3D, we observed that the infectivity of both T1L and T1L/T3DM2 was unaffected by neuraminidase treatment (Fig. 7A) , consistent with previous reports (14) . We next tested the capacity of GST-JAM-A to block infection by T1L and T1L/T3DM2. GST-JAM-A is composed of an N-terminal fusion of GST with the extracellular portion of JAM-A and has previously been used to measure the binding affinity of reovirus to JAM-A (23) . For these experiments, GST-JAM-A was incubated with each virus strain overnight and the capacity of these viruses to establish infection in L929 cells was measured by indirect immunofluorescence. We observed equivalent (ϳ 5-fold to 7-fold) decreases in infection of T1L and T1L/ T3DM2 with GST-JAM-A (Fig. 7B) . The decrease in infectivity of T1L and T1L/T3DM2 matched the diminishment in the attachment efficiency of both of these viruses (Fig. 7C) . These data indicate that both T1L and T1L/T3DM2 utilize JAM-A as the receptor to start infection.
Based on the results presented above, we hypothesized that T1L/T3DM2 might engage JAM-A more efficiently than T1L. To test this idea, we performed a plate-based in vitro binding assay. For these experiments, the capacity of increasing amounts of reovirus particles to bind plates coated with the extracellular portion of JAM-A (lacking GST) was assessed. At each virion concentration used, we found that T1L and T1L/T3DM2 bound to JAM-A with equivalent levels of efficiency (Fig. 7D) . These data indicate that virions of T1L and T1L/T3DM2 do not display differences in the capacity to bind JAM-A in vitro.
The results presented above indicate that 1 and JAM-A contribute to the differences in the attachment and infectivity of T1L and T1L/T3DM2 (Fig. 5 and 7B and C) . However, in vitro data suggest that the binding efficiencies of T1L and T1L/T3DM2 for the extracellular portion of JAM-A are comparable (Fig. 7D) . One possible explanation for these incongruent results may be that the amount of JAM-A needed for in vitro experiments far exceeds the amount of JAM-A present on cells. Indeed, we have observed no detectable binding of virions to a plate coated with lower concentrations of JAM-A (data not shown). It is also conceivable that the bacterially expressed extracellular portion of JAM-A differs from that of the native full-length JAM-A present on cells based on its posttranslational modification, the presence of the transmembrane and cytoplasmic portion of JAM-A, or its capacity to interact with other cellular molecules.
To evaluate the latter possibility, we utilized CHO cells that are poorly permissive with respect to infection by type 1 reovirus strains (38) . In CHO cells transfected with vector alone, the infectivity of both T1L and T1L/T3DM2 was low, with T1L/T3DM2 displaying slightly greater infectivity at higher MOIs (Fig. 8A) . Expression of human JAM-A in CHO cells increased their susceptibility to infection by 100 PFU/cell of both T1L and T1L/T3DM2 (Fig. 8A, left panel) . Interestingly, JAM-A-expressing CHO cells supported infection by T1L/T3DM2 to a greater extent than infection by T1L. When the MOI was reduced to 20 PFU/cell, JAM-A expression appeared to increase infection only by T1L/ T3DM2, further indicating that JAM-A expression affects infection of T1L and T1L/T3DM2 to different magnitudes. In some cell types, T1L can use GM2 as an attachment receptor (14) . To rule out the possibility that the infectivity differences between T1L and T1L/T3DM2 are a function of GM2 engagement, we also compared the infectivities of these two viruses in JAM-A-expressing CHO cells treated with neuraminidase. Neuraminidase treatment diminished the infectivity of both T1L and T1L/T3DM2 in CHO cells to equivalent extents (Fig. 8B) . Consistent with this, the attachment efficiency of T1L/T3DM2 exceeded that of T1L in JAM- A-expressing cells that were pretreated with neuraminidase ( Fig.  8C) . These data suggest that expression of JAM-A is sufficient to produce the observed difference in the levels of attachment and infectivity of T1L and T1L/T3DM2. To corroborate these results, we utilized HeLa cells from which endogenous JAM-A was deleted using CRISPR-Cas9 editing. Flow cytometric analysis of JAM-A-deleted cells indicated that surface expression of JAM-A was undetectable in Ͼ99% of cells (data not shown). In comparison to the native cells, which displayed differences in the infectivity of T1L and T1L/T3DM2 (analogous to Fig. 1B) , cells lacking JAM-A were minimally infected by both T1L and T1L/T3DM2 (Fig. 8D ). Together, these data indicate that the 1-dependent difference in the levels of infectivity of T1L viruses is mediated by the JAM-A reovirus proteinaceous receptor.
DISCUSSION
Using a monogenic reassortant of prototype reovirus strains T1L and T3D, we present new evidence indicating that the reovirus 1 protein influences the infectivity of reovirus. Our work demonstrates that the presence of the reovirus T3D-derived 1 protein in a T1L background promotes infection by increasing the cell attachment efficiency of the virus. The infection-enhancing property of 1 was attributable to its central jelly-roll ␤-barrel domain and required the presence of T1L 1. Viruses expressing this part of 1 utilized the cellular receptor JAM-A (engaged by 1) more efficiently and were therefore capable of establishing infection more readily. This work highlights that the 1 reovirus outercapsid protein affects the function of another outer-capsid protein, reovirus attachment factor 1.
The 1 and 1 proteins are not adjacent on the reovirus particle and do not make physical contact with each other (4, 5). Therefore, how 1 can affect the function of 1 is not clear. Our data indicate a role for the central portion of 1 in controlling the attachment efficiency of the reovirus particle. The central portion of 1 also controls the strain-specific differences in the capacity of reovirus to penetrate cell membranes during cell entry (17, 18) . Penetration of cell membranes by reovirus is mediated by the 1 N-terminal fragment, 1N (39) (40) (41) . 1N is buried in the native particle, and its release for membrane interaction requires the proteolytic removal of the 3 protector protein and conformational transitions in the trimer formed by 1 (31, 42) . The central region of 1 that we identified as controlling the cell attachment efficiency of T1L 1 also affects 1 intratrimer interactions. Changes in this region alter the efficiency with which 1 undergoes conformational transitions (17, 18, (43) (44) (45) (46) . We previously demonstrated that a single polymorphic difference between T1L and T3D 1 (at amino acid 305) within this region controls strainspecific differences in the cell penetration function of T1L and T3D 1 (18) . However, our results presented here indicate that T1L-T3D polymorphic changes at this residue are not sufficient to influence the cell attachment efficiency of an otherwise T1L virus (Fig. 3C) . Thus, the effect of 1 on cell attachment properties and membrane penetration efficiency are genetically separable. However, the possibility that differences in the interactions between 1 monomers within a 1 trimer influence the structure of the viral particle cannot be ruled out. Indeed, this region of 1 can also influence interactions between 1 and the 3 protector protein (4, 5) . Though not via this central region, 1 also makes contact with the 2 protein and the reovirus core (4, 5) . Whether any of these interactions are altered in T1L particles expressing T3D 1 and, if so, how such modified interactions can affect the function of 1 remain to be determined. The 1and 1-encoding gene segments (S1 and M2) have been previously implicated in controlling the same phenomena. The tropism of reovirus to the intestine and the central nervous system is linked to S1 and M2 (47) (48) (49) (50) . The viral S1 and M2 genes also control the capacity of reovirus to infect the liver and produce oily fur syndrome (51, 58) . Similarly, the induction of immune tolerance following oral administration of reovirus is also determined by the S1 and M2 gene segments (52) . While reovirus replication efficiency in the intestine is correlated with the sensitivity of the 1 protein to digestion by intestinal proteases (50) , the molecular basis of how 1 affects these predominantly 1-dependent properties remains unknown. In addition to these in vivo phenomena, strain-specific differences in the capacity of reovirus to elicit apoptosis and block host DNA synthesis in cell culture are also linked to S1 and M2 gene segments (26) (27) (28) . Whether these cellular responses to infection are independently controlled by S1 and M2 gene products or whether S1 and M2 gene products cooperate to control the same event in viral replication and thereby produce these effects on the cells has not been elucidated. Previous work suggests that appropriate subcellular localization of 1 fragments released from incoming virus particles or newly synthesized 1 may directly influence proapoptotic signaling (53) (54) (55) . Our work presented here indicates that 1 can also affect cell death by potentiating the attachment function of 1. We speculate that a few of the other phenotypes that are controlled by both S1 and M2 may also be consequences of the effect of 1 on 1 function. Reassortment between related strains of segmented viruses oc-curs both in cell culture and in vivo (56) . In a previous study of reovirus reassortment in vivo, mice were perorally inoculated with a mixture of T1L and T3D and the virus clones produced from such a mixed infection were analyzed (57) . It was determined that ϳ10% of the ϳ1,200 virus clones analyzed were reassortants of T1L and T3D. The frequencies of reassortment between pairs of genes appear to be nonrandom, and only 5 types of reassortants were isolated. Among these, a reassortant containing a T1L S1 gene and a T3D M2 gene (similar to what we analyzed and characterized in this study) was recovered with high frequency.
Whether the unusually high representation of this reassortant in the progeny is related to the replication advantage that we have described remains to be determined. Analysis of reassortant viruses has been invaluable in assignment of function to many viral proteins. Reassortment can produce progeny viruses with new properties that differ from those of either parent. In some cases, these phenotypes are additive such that a reassortant virus that receives different virulence-enhancing genes from two parents is more pathogenic than each of the parental strains. In other cases, a newly generated reassortant strain can display properties that are distinct from those of either parent. The mechanistic basis of how reassortment produces a completely new phenotype is not known. One possible explanation for these observations is the generation of additional accommodating mutations within the viral genome that contribute to the new phenotype. Another possibility is that the new phenotypes are produced as a consequence of the presence of a particular combination of gene products from different parental strains. Data presented here highlight the latter, often-underappreciated effect of reassortment.
